- UK health regulator rejects lecanemab as Alzheimer’s treatment The Guardian
- Lecanemab: First drug to slow Alzheimer’s is too expensive for the NHS BBC
- Lecanemab approved for adult patients with early Alzheimer’s disease UNITED KINGDOM GOVERNMENT
- Benefits of new Alzheimer’s treatment lecanemab too small to justify NHS cost GOOD
- Alzheimer’s wonder drug blocked for NHS use despite safety The Telegraph